SecBot SecBot
144 ·Filed Jun 29, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001964306-26-000299
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for the actual sale on Form 4 to confirm execution. The $2.7M sale is modest relative to the $2.2B market cap and follows recent insider selling patterns. No immediate price catalyst, treat as routine portfolio diversification by an officer.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$26.88
T+0 close · Jun 29, 2026 · via day close
Latest settled
+9.38%
T+60 · $29.40
Vs SPY
+4.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $26.88entry
  2. T+1 · 5mo ago +0.37%α −0.41% · $26.98
  3. T+5 · 4mo ago +8.33%α +6.95% · $29.12
  4. T+20 · 4mo ago −0.63%α −0.35% · $26.71
  5. T+60 · 8w ago +9.38%α +4.99% · $29.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Eric Warren, an officer of Mineralys Therapeutics, filed a Form 144 notice of intent to sell 104,124 shares of common stock, with an approximate market value of $2.7 million based on the filing date. The shares were acquired via a cashless exercise of employee stock options on June 26, 2026. This is a routine insider sale by an officer, not a transformative event, and the filing signals intent to sell, not a completed transaction.

Key Facts

  • Filer: Eric Warren, an officer of Mineralys Therapeutics
  • Shares to be sold: 104,124 shares of common stock
  • Approximate market value: $2,696,321.98 (based on filing date price of ~$25.90/share)
  • Acquisition: Shares acquired via cashless exercise of employee stock options on June 26, 2026
  • Broker: Merrill Lynch, 225 Liberty Street, New York, NY
  • Filing date: June 29, 2026; proposed sale date: June 26, 2026
  • Exchange: NASDAQ
  • Recent insider activity (30d): 3 sells totaling $425K prior to this filing

Financial Impact

Proposed sale of 104,124 shares valued at approximately $2.7 million, representing about 0.12% of the company's $2.2B market cap

dilutioninsider holdings

Risk Factors

  • Insider selling ahead of potential negative catalysts (e.g., clinical trial readouts, regulatory decisions) could signal lack of confidence
  • Accumulation of insider sales over time may weigh on sentiment if not offset by insider buying

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000299
Document: 0001964306-26-000299-index.html0001964306-26-000299
Document: 0001964306-26-000299.txt0001964306-26-000299

Track record

35 reports on MLYS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.

Filters
  1. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
  2. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
  4. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
  6. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  7. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  8. Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
  9. Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
  10. Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 8h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 29, 2026